Drug Trial Radar · NCT04442490
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)
Last checked: Nov 20, 2026Latest source record: Dec 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
543
Actual
Start
May 12, 2020
Primary completion
Mar 26, 2021
Study completion Apr 21, 2021
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Jun 22, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study to evaluate the efficacy of SAGE-217 in the treatment of participants with MDD.
Conditions
- Depressive Disorder, Major
Interventions
SAGE-217Drug
SAGE-217 oral capsules.
PlaceboDrug
SAGE-217 matched-placebo oral capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the 17-item HAM-D Total Score at Day 15Time frame: Baseline, Day 15
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Sage Investigational Site
Rogers, Arkansas
Sage Investigational Site
Bellflower, California
Sage Investigational Site
Garden Grove, California
Sage Investigational Site
Glendale, California
Sage Investigational Site
Lemon Grove, California
Sage Investigational Site
Orange, California
Sage Investigational Site
Pico Rivera, California
Sage Investigational Site
Redlands, California
Sage Investigational Site
San Diego, California
Sage Investigational Site
Sherman Oaks, California
Sage Investigational Site
Temecula, California
Sage Investigational Site
Coral Springs, Florida
Sage Investigational Site
Hollywood, Florida
Sage Investigational Site
Jacksonville, Florida
Sage Investigational Site
Lauderhill, Florida
Sage Investigational Site
Orange City, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Alpharetta, Georgia
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Decatur, Georgia
Sage Investigational Site
Skokie, Illinois
Sage Investigational Site
Flowood, Mississippi
Sage Investigational Site
O'Fallon, Missouri
Sage Investigational Site
Las Vegas, Nevada
Sage Investigational Site
Marlton, New Jersey
Sage Investigational Site
Charlotte, North Carolina
Sage Investigational Site
Cincinnati, Ohio
Sage Investigational Site
Dayton, Ohio
Sage Investigational Site
North Canton, Ohio
Sage Investigational Site
Oklahoma City, Oklahoma
Sage Investigational Site
Portland, Oregon
Sage Investigational Site
Allentown, Pennsylvania
Sage Investigational Site
Charleston, South Carolina
Sage Investigational Site
Memphis, Tennessee
Sage Investigational Site
DeSoto, Texas
Sage Investigational Site
Wichita Falls, Texas
Sage Investigational Site
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.